Analysis of oral and pulmonary mycoses in suspected subjects of pulmonary tuberculosis visiting Indian healthcare center
Keywords:
aspergillosis, candidiasis, fungal infection, pulmonary mycoses, pulmonary tuberculosisAbstract
Background: Fungal infection of the lungs caused by endemic, opportunist, or combined fungi is pulmonary mycosis comprising a wide range of fungal diseases commonly seen in debilitated or immunocompromised subjects. Aims: To identify the pulmonary mycoses occurrence in suspected subjects of pulmonary tuberculosis (TB) by identifying and isolating various fungi causing pulmonary mycoses. Methods: 400 samples were taken from 200 suspected subjects of pulmonary TB where acid-fast staining was done to identify AFB (acid-fast bacilli), KOH, and gram stain to assess fungal element presence followed by culture on SDA to study fungal morphology. Germ-tube test used for C. Albicans identification. Results: Pulmonary mycosis was seen in 58 study subjects where candida species were the most commonly isolated fungal organism seen in 51.72% (n=30) study subjects followed by Aspergillus Niger, which was isolated in 20.68% (n=12) study subjects from their sputum. Candida albicans were most common and were isolated in 7 males where 3 were in the age of 11-20 years and 4 in 31-40 years, whereas Candida species were isolated from 23 females where in 11-20, 41-50, and 51-60 years had 3 females each, 61-70 years range had 5 females, and 9 females were in the age of 71-80 years.
Downloads
References
Babita SS, Prabhat K. Prevalence of mycotic flora with pulmo¬nary tuberculosis patient in a tertiary care hospital. Int J Con¬temp Med Res 2016;3:2563-2564.
Bansod S, Rai M. Emerging of Mycotic infection in patients infected with Mycobacterium tuberculosis. World J Med Sci 2008;3:74-80.
Biswas D, Agarwal S, Sindhwani G, Rawat J. Fungal coloni¬zation in patients with chronic respiratory diseases from the Himalayan region of India. Ann Clin Microbiol Antimicrob 2010;9:28.
Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Resp J 2007;30:782-800.
Buthia T, Adhikari L. Pulmonary mycoses among the clinically suspected cases of pulmonary tuberculosis. Int J Res Med Sci 2015;3:260-8.
Chadeganipour M, Shadzi S, Dehghan P, Bijary J. The incidence of opportunistic fungi in patients suspected of tuberculosis. My¬coses 2000;43:269-72.
Jasmer RM, Nahid P, Hopewell PC. Latent tuberculosis infec¬tion. New Engl J Med 2002;347:1860-6.
Jha BJ, Dey S, Tamang MD, Joshy ME, Shivananda PG, Brah¬madatan KN. Characterization of Candida species isolated from cases of lower respiratory tract infection. Kathm Univ Med J 2006;4:290-4.
Kali A, Charles MP, Noyal MJ, Sivaraman U, Kumar S, Easow JM. Prevalence of Candida co-infection in patients with pulmo¬nary tuberculosis. Aus Med J 2013;6:387.
Khidoyatova, M. R., Kayumov, U. K., Inoyatova, F. K., Fozilov, K. G., Khamidullaeva, G. A., & Eshpulatov, A. S. (2022). Clinical status of patients with coronary artery disease post COVID-19. International Journal of Health & Medical Sciences, 5(1), 137-144. https://doi.org/10.21744/ijhms.v5n1.1858
Latha R, Sasikala R, Muruganandam N, Babu RV. Study on the shifting patterns of Non-Candida Albicans Candida in lower res¬piratory tract infections and evaluation of the CHROMagar in the identification of the Candida species. J Microbiol Biotechnol Res 2011;1:113-9.
Meersseman W, Lagrou K, Maertens J, Wijngaerden EV. In¬vasive aspergillosis in the intensive care unit. Clin Infect Dis 2007;45:205-16.
Njunda AL, Ewang AA, Kamga LH, Nsagha DS, Assob JC, Ndah DA, Kwenti TE. Respiratory tract Aspergillosis in the sputum of patients suspected of tuberculosis in Fako division- Cameroon. J Microbiol Res 2012;2:68-72.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
